- Lobbying
- Lobbying by Bristol-Myers Squibb
Lobbying Relationship
Bills mentioned
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
H.R.5651: Food and Drug Administration Reform Act of 2012
Sponsor: Fred Upton (R-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Steve Tilton | HCRPolicyCoor/SenPolAdvr:Energy/CommerceComm,Bilirakis |
J. Michael Hogan Jr. | DepCoS, Ben Nelson; LegDir, Peter Deutsch |
John O'Neill | PolDir/Coun,SenMinWhip;Couns,SenFinComm |
Gordon Taylor | COS/LD/Coun,John;Leg Asst/Press Secy,Hayes |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate